|
Post by mnkdfann on Jan 18, 2019 17:17:49 GMT -5
Zacks = click bait. Just ignore what they write. Zacks writes what they are paid to write. "Those who cannot remember the past are condemned to repeat it." INVESTMENT BANKING AND FEES FOR SERVICES Zacks SCR does not provide investment banking services nor has it received compensation for investment banking services from the issuers of the securities covered in this report or article. Zacks SCR has received compensation from the issuer directly or from an investor relations consulting firm engaged by the issuer for providing non-investment banking services to this issuer and expects to receive additional compensation for such non-investment banking services provided to this issuer. The non-investment banking services provided to the issuer includes the preparation of this report, investor relations services, investment software, financial database analysis, organization of non-deal road shows, and attendance fees for conferences sponsored or co-sponsored by Zacks SCR. The fees for these services vary on a per-client basis and are subject to the number and types of services contracted. Fees typically range between ten thousand and fifty thousand dollars per annum. Details of fees paid by this issuer are available upon request.
|
|
|
Post by mnkdfann on Jan 18, 2019 12:09:38 GMT -5
Everything I follow is green today, except TSLA, MNKD, and SPXU.
|
|
|
Post by mnkdfann on Jan 18, 2019 10:48:14 GMT -5
They previously had a $500M offer on the table for 51% and refused. I bet they would jump for that chance right now. Double their current MC and keep 50% Silly wabbit.
|
|
|
Post by mnkdfann on Jan 18, 2019 10:37:28 GMT -5
They previously had a $500M offer on the table for 51% and refused. When / with whom was that? Is this the guy who stood up at the annual meeting and made some offer to invest bigly on behalf of some fund or something? (Seriously, IIRC there was such an incident.)
|
|
|
Post by mnkdfann on Jan 17, 2019 17:19:11 GMT -5
Someone (Mike C) at MNKD needs to contact Congressman Elijah Cummings, well in advance of his hearing with big pharma,, to explain our direct purchase program and the need for it. He needs to understand the pricing issues with the middle men, exclusivity w/rebates, and the costs associated with developing new drugs. Mike should explain in painful detail the 2 CLR’s and Martin Shirelli’s influence with the FDA that almost killed Afrezza. Other pharmas also have programs. Lilly Cares for instance provides free medications to many, and (AFAIK) does not limit it to 1000 patients.
|
|
|
Post by mnkdfann on Jan 17, 2019 15:42:29 GMT -5
Two enquires/opinions. 1. Since Symphony uses rx numbers from pharmacies, will these new program rxs be excluded from the weekly Friday numbers? 2. Would be nice if MNKD, once the 1000 people are enrolled to put out a PR. Something like 1000 people were enrolled in under 1 week. Scripts had better increase significantly (up by at least several hundred) over the next 3 to 4 months, or shorts will be screaming how Mannkind cannot even (practically) give it (Afrezza) away. If Eagle is not reporting the new scripts to Symphony, then Mannkind should make that known so shorts do not misrepresent the script numbers being released each week. And I had a Big Pharma conspiracy thought. If BP is as active at hurting Mannkind and frustrating Afrezza's acceptance as some claim, is it remotely possible for agents / puppets of BP to sign up for many (if not most) of the 1000 registrations in order to keep them out of the hands of those they were really meant for?
|
|
|
Post by mnkdfann on Jan 16, 2019 23:41:20 GMT -5
ST......@rooksleanne I wonder if Canada and Mexico can access this Pharmacy? From BigCheeze Another consideration is that a doctor in Canada is not allowed to prescribe Unapproved Drugs (i.e. drugs not approved in Canada), except in very limited cases. That is discussed at the link below. www.cpso.on.ca/Policies-Publications/Policy/Prescribing-DrugsDrugs that have not been Approved for Use in Canada (‘Unapproved Drugs’) Physicians must not prescribe drugs that have not been approved for use in Canada, that is, drugs for which Health Canada has not issued a Notice of Compliance (NOC). However, there are two circumstances when access to an unapproved drug can be obtained for patient use. The first is when drugs have been authorized by Health Canada for research purposes as part of a clinical trial. The other is when drugs have been authorized under Health Canada’s Special Access Programme. (AFAIK, Afrezza has neither authorization.)
|
|
|
Post by mnkdfann on Jan 16, 2019 23:31:40 GMT -5
ST......@rooksleanne I wonder if Canada and Mexico can access this Pharmacy? From BigCheeze www.insulinsavings.com/Terms and Conditions for Direct Purchase Program Offer This Offer is available to patients ages 18 and over with a valid prescription for Afrezza® (insulin human) Inhalation Powder. Must be a U.S. resident, with a valid U.S. shipping address to qualify.
|
|
|
Post by mnkdfann on Jan 16, 2019 10:53:30 GMT -5
This is one (the only one) of MC's posts on the Afrezza Facebook page I found from yesterday: "All details are here but generally if you have insurance through your employer yes. afrezza.copaysavingsprogram.com/"
One line. Were there others posts by MC? Maybe, but that's the only one I saw / could find. People may be over-imagining how much MC posted on FB, or how much time it took him to do so. That's the reply. One simple reply by MIKE, yet...not worth all the time spent here if it weren't for the misdirection of one poster. I made a comment to let others know that he was on FB helping a patient navigate their insurance and it resulted in a question of judgment and organizational skills. Sad, but true. I think you're correct in the 'imagination' of some. However, this thread is about commercials and we need to keep it on track, too. To be fair, the earlier statement "Mike was on FB "Afrezza Users Group" yesterday, helping out patients with insurance problems they had last week. Looks like success based on replies.", made it sound (to some, including myself) that there was more than one post, and he was responding individually to multiple patients. But it's all good.
|
|
|
Post by mnkdfann on Jan 16, 2019 10:36:46 GMT -5
In my opinion, Mike must delegate control of the function described above to someone else in the organization. It is not the best use of his time as CEO and raises questions in my mind about judgement and organizational skills at MNKD. This is actually the thing I like most about Mike and mnkd, and definitely shows how passionate Mike is about making sure first hand that PWD are having a smooth transition from RAA’s to Afrezza. This also reflects good on the Company and the concept that “Mannkindcares”, I mean really !! The CEO is helping with transitional problems via Facebook !! Im sure that experience is a first for every PWD that Mike has helped, regardless of how, Facebook or other means. Great work Mike !! 👏🏻👏🏻👏🏻👏🏻👏🏻👏🏻 This is one (the only one) of MC's posts on the Afrezza Facebook page I found from yesterday: "All details are here but generally if you have insurance through your employer yes. afrezza.copaysavingsprogram.com/"
One line. Were there others posts by MC? Maybe, but that's the only one I saw / could find. People may be over-imagining how much MC posted on FB, or how much time it took him to do so.
|
|
|
Post by mnkdfann on Jan 14, 2019 21:30:38 GMT -5
Did you notice how, with that last , liane finally revealed her true personality? Somali pirate?
|
|
|
Post by mnkdfann on Jan 14, 2019 19:27:40 GMT -5
As I noted in my second post in this thread, it ended up that Mannkind was NOT called to testify. So discussions about what it might say seem to be irrelevant. Unless it can invite itself, which may not be a wise thing to do.
|
|
|
Post by mnkdfann on Jan 14, 2019 19:24:17 GMT -5
But you can still hard-code them in quick replies, using the punctuation keys. Like this one was:
|
|
|
Post by mnkdfann on Jan 14, 2019 16:59:02 GMT -5
Oh, here we are ... looks like Mannkind dodged that bullet: www.cnbc.com/2019/01/14/house-democrats-launch-drug-pricing-probe-on-a-dozen-companies.html"Chairman Elijah Cummings, D-Md., sent letters to AbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals seeking detailed information and documents about the companies' pricing practices."
|
|
|
Post by mnkdfann on Jan 14, 2019 16:55:10 GMT -5
I was GOING to say, it's a good thing Mannkind is a small enough player that it escapes scrutiny. But then I read the article more closely and noticed the line: "Insulin prices also spiked: Sanofi and Novo Nordisk each raised prices on branded insulins by roughly 5 percent, while MannKind Corp. hiked the price of its inhalable insulin Afrezza by 9 percent." So I wonder if Rep. Cummings will call Mannkind to testify?
|
|